BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15290726)

  • 1. Serological bone markers and joint damage in early polyarthritis.
    Jansen LM; van der Horst-Bruinsma I; Lems WF; van Schaardenburg D; van de Stadt R; de Koning M; Dijkmans BA
    J Rheumatol; 2004 Aug; 31(8):1491-6. PubMed ID: 15290726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
    J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products.
    Garnero P; Jouvenne P; Buchs N; Delmas PD; Miossec P
    Bone; 1999 Apr; 24(4):381-5. PubMed ID: 10221550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis.
    Ben Achour W; Bouaziz M; Mechri M; Zouari B; Bahlous A; Abdelmoula L; Laadhar L; Sellami M; Sahli H; Cheour E
    Libyan J Med; 2018 Dec; 13(1):1512330. PubMed ID: 30160204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
    Garnero P; Landewé R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P
    Arthritis Rheum; 2002 Nov; 46(11):2847-56. PubMed ID: 12428224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
    Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
    J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M; Jakubicz D; Stepień K; Cicha M
    Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
    Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
    Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
    Hashimoto J; Garnero P; van der Heijde D; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Yoshikawa H; Nishimoto N
    Mod Rheumatol; 2009; 19(3):273-82. PubMed ID: 19452245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional evaluation of bone metabolism in men.
    Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
    J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years.
    Jansen LM; van der Horst-Bruinsma IE; van Schaardenburg D; Lard LR; Hazes JM; Huizinga TW; Dijkmans BA
    Clin Exp Rheumatol; 2004; 22(4):447-52. PubMed ID: 15301242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
    Verstappen SM; Poole AR; Ionescu M; King LE; Abrahamowicz M; Hofman DM; Bijlsma JW; Lafeber FP;
    Arthritis Res Ther; 2006; 8(1):R31. PubMed ID: 16507130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.
    Weinbrenner T; Zittermann A; Gouni-Berthold I; Stehle P; Berthold HK
    Eur J Clin Nutr; 2003 Oct; 57(10):1262-7. PubMed ID: 14506487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
    Landewé RB; Geusens P; van der Heijde DM; Boers M; van der Linden SJ; Garnero P
    Ann Rheum Dis; 2006 Jan; 65(1):40-4. PubMed ID: 16126801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Filippucci E; Grassi W
    BMC Musculoskelet Disord; 2011 May; 12():120. PubMed ID: 21624120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.